Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/7894
Title: Biologic agents and tuberculosis
Authors: Claudia Dobler 
Issue Date: 27-Apr-2017
Journal: Tuberculosis and Nontuberculous Mycobacterial Infections
Abstract: In recent years, the market of biopharmaceuticals has been growing at a fast pace due to increased availability of targets for biologic agents, approval of biologic agents for new and expanded indications, and increased use of these medications. Biopharmaceuticals, also known as biologic products or agents, biologics, or biologicals, are drugs that are produced through biological processes rather than chemical synthesis. These include recombinant proteins, monoclonal and polyclonal antibodies, peptides, antisense oligonucleotides, therapeutic genes, and recombinant and DNA vaccines. Biopharmaceuticals usually require infusion or injection rather than oral application.
Appears in Sites:Publication workflow
Queensland Health Publications

Show full item record

Page view(s)

2
checked on Jul 10, 2025

Google ScholarTM

Check


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.